RespiCare

Transcription

RespiCare
RespiCare
Spiropraxy Chair ®
®
The RespiCare® is a medical device that enables the practice of ventilatory exercises. It is conceived
as a preventive health measure or as complement to a respiratory therapy intervention.
The RespiCare® enables the performance of specific exercises that are beneficial to the ventilation
development and increases the respiratory consciousness.
The inability of the respiratory system
to ensure a proper oxygenation of the
tissues is often the cause of several
lung diseases, as well as muscular,
spinal or postural diseases.
The RespiCare® is a prevention device for all
these diseases.
It is also a tool to reinforce the therapy
actions in the field of the respiratory
disorders and its consequences.
The RespiCare® is available in two versions:
• For an oxygen free use, or with the use of an external oxygen concentrator
• With an integrated oxygen concentrator that provides 30% of oxygen.
Oxygen and Breath of life
Therapeutic Indications
The RespiCare® provides support in the primary, secondary and tertiary preventions.
In the Primary prevention, in patients at risk, the RespiCare® chair finds its place in the medical or
paramedical environment before the illness or decompensation appears.
The following fields are the most concerned by the primary prevention:
• Stress and anxiety, the most frequent factors of inspiratory muscles spasms.
• Smoking, as a complement of the cessation, to improve the management of the induced stress,
and reinforce the cognitive-behavioural support which is critical for the success.
• Obesity, complementing the changes in lifestyle and diet.
• Aging, to promote the restoration of the thoracic spinal movement amplitude that decreases due to
the age-related muscle atony.
Regarding the Secondary prevention, the RespiCare® chair provides support to the treatments that prevent
the aggravations of the disease through an active therapy optimization.
Restrictive Lung Disease
• Deficiency linked to the tidal volumes reduction
• Pulmonary rehabilitation needs and recovery of the lost lung
volume.
• Interstitial lung disease, pulmonary fibrosis, drugs interactions
in pneumopathy
• Lobectomy after-effects, pneumonectomy (postoperative)
• Kyphoscoliosis, obesity
• Pleural sequelae, pneumothorax
• Central neurological impairment, neuromuscular diseases
Obstructive Lung Disease
Inspiration
• Deficiency related to the respiratory flow reduction
• Deficiency in gas exchange (by insufficient tidal volumes)
• Need to optimize by the optional supply of medical oxygen to reinforce the active therapy
• Chronic obstructive pulmonary disease
• Asthma
• Emphysema
Expiration
In the Tertiary Prevention
Upon recovery or stabilization, the RespiCare® chair holds a special
place in the lung rehabilitation strategy.
The aim is to prevent recurrence or relapse by reinforcing the respiratory
capacity and by managing the stress and anxiety. This is achieved thanks
to specific programs included in the settings of the RespiCare®
chair.
From the primary prevention, to providing support during the disease and reinforcing after the stabilization
is achieved, the chair RespiCare® is an asset for any intervention in the area of the respiratory and related
diseases.
Innovation and Technology
The objective of the RespiCare® chair is to restore and increase the depth of respiration of the subject in order to
increase the lung capacity, thus enabling the gas exchange of the physiological breathing.
The active system of the RespiCare® chair impulses
progressive thrusts at the spine level. The rhythm of
the thrusts and of its pressure is adjustable depending on the objectives and desired progressivity.
The person is installed in a sitting position -reverse
trendelenburg- with the weight evenly distributed,
allowing a good hemodynamic and being effortless
for the heart.
Ventilatory cycle involvement in the respiratory physiomechanical area: vertebrae L3 to T10.
End of cycle, maximum thoracic amplitude.
Complementing the mechanical action, a pre-programmed software that can be adjusted by the practitioner,
accompanies vocally and with music the rhythm of the thrusts.
The biomechanical effect of the RespiCare® promotes
the contraction of the external intercostals muscles,
increasing the volume of the rib cage by lowering
the diaphragm. The natural descent of the viscera
amplifies the volume of the thoracic cage and
increases the inspiratory volume.
This increase in tidal volume enables a greater
respiratory gas exchange. A regular training
in the RespiCare® significantly enhances
the lung capacity.
For patients requiring oxygen supply,
the exercises can be provided with
the implementation of medical oxygen.
Thrusts
zone
The RespiCare® can be used concurrently with a medical oxygen supplementation.
If the oxygen source is a portable or fixed concentrator, it can be placed next to the RespiCare®
and be used as usual following the medical prescription.
It enables a greater gas exchange in the pulmonary alveoli.
SCALEO® Medical offers a range of portable and stationary concentrators of up to 5 liters in continuous flow.
SCALEO® Stationary concentrator of
5L in continuous flow and 14.4 Kgs.
Portable concentrators Inogen®
G2 and G3 - the quietest and smallest of the market.
Inogen® Stationary concentrator
of 5L in continuous flow and only
8.3 Kgs.
Technical Features
RespiCare®
RespiCare®
O2 inside
Weight
104 kg
111 kg
Electrical
compatibility
220/110 V - Adapted plug
Dimension
1250 x 800 x 1150 (lxwxh)
Dimension
active position
1800 x 800 x 950 (lxwxh)
Oxygen
External
medical
O2 concentrator
Integrated
concentrator
Scaleo® Medical
Oxygen and Breath of life
107 Dassin street, Parc 2000 - 34080 Montpellier
Ph: +33 (0)4 67 72 94 86 - Fax : +33 (0)4 99 74 01 79
www.scaleomedical.fr - info@scaleomedical.com
Ref. DO MA682 May 1st, 2016- Non contractual document. The manufacturer reserves the right to improve the characteristics and/or features of the presented products.
Using RespiCare® with oxygen